Tepotinib in second line NSCLC treatment
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of October October 26th - 31st.
Dr Morgan covers papers from New England, JCO Oncology, The Lancet, ASTRO, as well as a list of FDA announcements.
Dr Morgan reports that AACR have announced that their 2021 meeting will be virtual.
Finally tune into the OncoAlert podcast for discussions on #BlackInCancer, #HispanicsInMedicine, and financial toxicity.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Tepotinib in second line NSCLC treatment
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert round up July 28th to August 3rd, 2023